FCN3 and systemic inflammatory response syndrome: Indeed, patients who developed SIRS and MODS with ficolin-3 levels ≤ 25th percentile had generally a much better prognosis [91% survival vs. 37%; OR = 16.7; 95% CI (1.7–164.9); p = 0.007].